about
From patient centered risk factors to comprehensive prognostic models: a suggested framework for outcome prediction in umbilical cord blood transplantation.Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationEffect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantationStem cells and regenerative medicine: accomplishments to date and future promise.How I treat: the selection and acquisition of unrelated cord blood grafts.Cellular therapies in acute lymphoblastic leukemiaFrequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.Going straight to the point: intra-BM injection of hematopoietic progenitors.Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs.Cord blood graft composition impacts the clinical outcome of allogeneic stem cell transplantation.Unrelated cord blood transplantation in pediatric patients: a report from Saudi Arabia.Assessment of Platelet Activation and Immature Platelet Fraction as Predictors of Platelet Engraftment After Hematopoietic Stem Cell Transplantation.Haploidentical stem cell transplantation for children with high-risk leukemia.
P2860
Q33766984-B3C432DB-CFCA-46C6-9BED-351A4CEDA4C0Q33780277-75F31D88-A211-435E-97D7-7C334F04F65BQ34033553-75732229-A039-4EA6-9754-35CA1DE064A0Q34343825-EC92111F-3F9A-4BE7-BA57-708152C6A3B4Q34707580-CD8EDD6B-508B-4228-9170-65AA1D4C7A73Q36552098-2CE35B96-D2C9-4965-A8BD-70F9C9B17C8EQ36902123-1A19534F-C669-4CE8-8BC9-803D874BFCFCQ37214330-1027BEE2-8EE2-4F2A-9DEA-5CA6DE1A0445Q37715706-5A5A43A0-8C85-431E-B586-E1F1330F14C3Q37785538-237F46C4-1787-472D-A1FA-8C269485CFD1Q38453666-BF92CE3C-4F44-4D2B-B087-5D5BE314A406Q42241622-6731A9CA-1D95-4190-805E-5339C713895BQ50156537-F436BAE1-BA3F-48D1-AF44-58B461EB9845Q52889068-430DAAF6-67DE-4AF3-9B17-D0F9AE73AF60Q53137621-AAAAFF73-125E-4B88-B9BC-BCBDDC409B3C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Optimizing unrelated donor cord blood transplantation.
@en
Optimizing unrelated donor cord blood transplantation.
@nl
type
label
Optimizing unrelated donor cord blood transplantation.
@en
Optimizing unrelated donor cord blood transplantation.
@nl
prefLabel
Optimizing unrelated donor cord blood transplantation.
@en
Optimizing unrelated donor cord blood transplantation.
@nl
P2093
P1476
Optimizing unrelated donor cord blood transplantation.
@en
P2093
Andromachi Scaradavou
Juliet N Barker
Vanderson Rocha
P304
P356
10.1016/J.BBMT.2008.10.020
P433
P577
2009-01-01T00:00:00Z